BACKGROUND: Gastric cancer is a leading cause of cancer deaths worldwide but there are few data from Africa. We recently observed a trend towards diagnosis in younger patients. OBJECTIVE: To test the hypothesis that HIV might have altered risk factors for acquisition of gastric cancer, in a case-control study in the University Teaching Hospital, Lusaka, Zambia. METHODS: Patients (n=52) with confirmed gastric adenocarcinoma and controls (n=94) undergoing endoscopy but with no macroscopic gastric pathology. Established risk factors and HIV status were compared. RESULTS: HIV status did not differ significantly between cases and controls (odds ratio 1.03; 95% CI 0.2 - 4.3; p=1.00) and seroprevalence in cases was similar to that of the Zambian population. Smoking, regular alcohol intake, and gastric atrophy were all associated with cancer in univariate and multivariate analysis. Helicobacter pylori serology was positive in 84% of patients studied and cagA serology in 66%; neither serological marker was associated with cancer. Atrophy was common in cases (57%) and controls (30%) and associated with both smoking and alcohol use. Intestinal metaplasia was present in 17% of the controls, but was not associated with atrophy. CONCLUSIONS: HIV was not associated with gastric cancer and does not explain the apparent younger age distribution. Atrophy was common and was not essential for the development of intestinal metaplasia, suggesting that gastric carcinogenesis in Africa does not always follow the pathway from atrophy to intestinal metaplasia to gastric carcinoma (the so-called Correa pathway).
BACKGROUND:Gastric cancer is a leading cause of cancer deaths worldwide but there are few data from Africa. We recently observed a trend towards diagnosis in younger patients. OBJECTIVE: To test the hypothesis that HIV might have altered risk factors for acquisition of gastric cancer, in a case-control study in the University Teaching Hospital, Lusaka, Zambia. METHODS:Patients (n=52) with confirmed gastric adenocarcinoma and controls (n=94) undergoing endoscopy but with no macroscopic gastric pathology. Established risk factors and HIV status were compared. RESULTS: HIV status did not differ significantly between cases and controls (odds ratio 1.03; 95% CI 0.2 - 4.3; p=1.00) and seroprevalence in cases was similar to that of the Zambian population. Smoking, regular alcohol intake, and gastric atrophy were all associated with cancer in univariate and multivariate analysis. Helicobacter pylori serology was positive in 84% of patients studied and cagA serology in 66%; neither serological marker was associated with cancer. Atrophy was common in cases (57%) and controls (30%) and associated with both smoking and alcohol use. Intestinal metaplasia was present in 17% of the controls, but was not associated with atrophy. CONCLUSIONS: HIV was not associated with gastric cancer and does not explain the apparent younger age distribution. Atrophy was common and was not essential for the development of intestinal metaplasia, suggesting that gastric carcinogenesis in Africa does not always follow the pathway from atrophy to intestinal metaplasia to gastric carcinoma (the so-called Correa pathway).
Authors: Arto Kokkola; Timo U Kosunen; Pauli Puolakkainen; Pentti Sipponen; Matti Harkonen; Frank Laxen; Jarmo Virtamo; Reijo Haapiainen; Hilpi Rautelin Journal: APMIS Date: 2003-06 Impact factor: 3.205
Authors: Y O Ahn; B J Park; K Y Yoo; N K Kim; D S Heo; J K Lee; H S Ahn; D H Kang; H Kim; M S Lee Journal: J Korean Med Sci Date: 1991-03 Impact factor: 2.153
Authors: Violet Kayamba; Allen C Bateman; Akwi W Asombang; Aaron Shibemba; Kanekwa Zyambo; Themba Banda; Rose Soko; Paul Kelly Journal: Cancer Med Date: 2015-01-30 Impact factor: 4.452
Authors: Violet Kayamba; Aaron Shibemba; Kanekwa Zyambo; Douglas Corbett Heimburger; Douglas Morgan; Paul Kelly Journal: Pan Afr Med J Date: 2018-10-22
Authors: Violet Kayamba; Julia Butt; Tim Waterboer; Ellen Besa; Naheed Choudhry; Anglin Hamasuku; Peter Julius; Douglas C Heimburger; Masharip Atadzhanov; Paul Kelly Journal: Cancer Med Date: 2020-03-24 Impact factor: 4.452